NASDAQ:INCY   Incyte Corporation
Biopharmaceutical company focused on the discovery, development and commercialization of therapeutics.
Double bottom
BUY 65.9
SL 64.5
TP1 69 TP2 75
Trade closed manually:
Target 1 $69 reached
Close at BE

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.